QUICK,
SIMPLE,
SCALABLE,
TRUST WORTHINESS
EVIDENCE-BASED DRIVEN

Plant-based Technology

QUICK,
SIMPLE,
SCALABLE,
TRUST WORTHINESS
EVIDENCE-BASED DRIVEN

Plant-based Technology

Image_02

"THE FIRST PLANT-PRODUCED BIOLOGICS COMPANY IN SOUTH EAST ASIA REGION."

Baiya Phytopharm Co., Ltd.’s mission is to strengthen health security for all people using our BaiyaPharming™ protein expression platform to produce recombinant molecular proteins.

BaiyaPharming™ protein expression platform provides quick, simple, and scalable platform for biopharma industry aiming to replace biotech’s  conventional  fermenter with plants. Biological products of interest  can be active ingredients in cosmetics,  diagnostic test kits, drugs or even vaccine industry.

Baiya Phytopharm™ was founded in 2018 as a spin-off company from faculty of pharmaceutical sciences, Chulalongkorn university, Thailand. With experiences from our co-founder, Waranyoo Poolcharoen, PhD, who has more than 15 years experiences in plant-produced protein expression system and Suthira Taychakhoonavudh, PhD, whose expertise is in health economics, Baiya Phytopharm offers a cutting-edge solution for biopharma industry. The platform has the flexibility to produce biopharmaceutical products of interest within weeks rather than months or years which resulted in a faster and lower cost of research and development.

Baiya Phytopharm™ was founded in 2018 as a spin-off company from faculty of pharmaceutical sciences, Chulalongkorn university, Thailand. With experiences from our co-founder, Waranyoo Poolcharoen, PhD, who has more than 15 years experiences in plant-produced protein expression system and Suthira Taychakhoonavudh, PhD, whose expertise is in health economics, Baiya Phytopharm offers a cutting-edge solution for biopharma industry. The platform has the flexibility to produce biopharmaceutical products of interest within weeks rather than months or years which resulted in a faster and lower cost of research and development.

Pipelines

Our products include plant-produced basic Fibroblast Growth factor (bFGF) or Baiya Plant FGF™  and plant- produced basic Epidermal Growth factor (bEGF) or Baiya Plant EGF™ as a potential anti-aging ingredient for cosmetics.

As pandemic of Covid-19 hits the globe in January 2020, Baiya Phytopharm has shifted its production capacity to produce SAR-CoV-2 related protein including RBD-His antigen protein,  human ACE2 protein, CR3022 monoclonal antibody. Baiya Phytopharm has launched Baiya Rapid Covid-19 IgG/IgM Test kit™ in March 2020 and has filed for Thai FDA approval for medical device in April 2020.

Other products in our pipeline include diagnostic test kits for human and animal, therapeutics and vaccines for human and animal.

Cosmetics Ingredients

- Baiya Plant FGF™
- Baiya Plant EGF™

COVID-19 Projects

- Plant-Based SARS-CoV-2 Spike protein (RBD, Histag)
- Recombinant Anti-SARS-CoV-2 Spike Glycoprotein S1 Antibody (CR3022)

Diagnostic test kit

- COVID-19 Antibody Test kit

News

Posts not found

Baiya’s phytopharm’s plant-based technology is a cutting-edge solutions that is quick, simple and scalable aiming to replace biotech’s fermenter with plants. The platform has the flexibility to produce biopharmaceutical products of interest within weeks rather than months or years which resulted in a faster and lower cost of research and development.

Team

Waranyoo Phoolcharoen

Waranyoo Phoolcharoen

CSO and Co-founder
Suthira Taychakhoonavudh

Suthira Taychakhoonavudh

CEO and Co-founder
Kittinop Kittirotruji

Kittinop Kittirotruji

Marketing manager
Apisit Burapapirun

Apisit Burapapirun

Researcher

Get In Touch

Address
6/5 onnut 74/1 onnut road (Sukhumvit 77) prewet Bangkok
10250

Email
info@baiyaphytopharm.com

Phone
(+66)98 745 0529

Facebook
@BaiyaPhytopharm

Baiya’s products

Cosmetics

COVID-19 Project

COVID-19 Project